ROTHBLATT MARTINE A sold UTHR
October 24, 2025 · Form 4 insider transaction
ROTHBLATT MARTINE A sold 500 shares of United Therapeutics Corporation at $426.40 per share, a transaction worth $213.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
500
Price
$426.40
Total value
$213.2K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 24, 2025
Filing dateOctober 27, 2025
Shares owned after130
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. This plan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025.